Versatility of the clone-censor-weight approach: response to "trial emulation in the presence of immortal-time bias"

Sizheng Steven Zhao¹, Houchen Lyu^{2

3}, Kazuki Yoshida⁴

Affiliations

¹ Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
² National Clinical Research Center for Musculoskeletal Diseases, General Hospital of Chinese PLA, Beijing, China.
³ Department of Orthopedics, General Hospital of Chinese PLA, Beijing, China.
⁴ Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.

Comment

Sizheng Steven Zhao et al. Int J Epidemiol. 2021.

. 2021 May 17;50(2):694-695.

doi: 10.1093/ije/dyaa223.

Sizheng Steven Zhao¹, Houchen Lyu^{2

3}, Kazuki Yoshida⁴

¹ Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
² National Clinical Research Center for Musculoskeletal Diseases, General Hospital of Chinese PLA, Beijing, China.
³ Department of Orthopedics, General Hospital of Chinese PLA, Beijing, China.
⁴ Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.

No abstract available

Comment in

Reply to: Versatility of the clone-censor-weight approach: response to ''trial emulation in the presence of immortal-time bias''.
Maringe C, Benitez Majano S, Exarchakou A, Smith M, Rachet B, Belot A, Leyrat C. Maringe C, et al. Int J Epidemiol. 2021 May 17;50(2):696. doi: 10.1093/ije/dyaa225. Int J Epidemiol. 2021. PMID: 33524137 Free PMC article. No abstract available.

Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data.
Maringe C, Benitez Majano S, Exarchakou A, Smith M, Rachet B, Belot A, Leyrat C. Maringe C, et al. Int J Epidemiol. 2020 Oct 1;49(5):1719-1729. doi: 10.1093/ije/dyaa057. Int J Epidemiol. 2020. PMID: 32386426 Free PMC article.